Bristol Myers Squibb Co. (BMY)
61.15
-0.31
(-0.50%)
USD |
NYSE |
Oct 02, 16:00
61.14
-0.01
(-0.02%)
After-Hours: 20:00
Bristol Myers Squibb Price to Book Value : 5.597 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.597 |
| October 01, 2026 | 5.626 |
| September 30, 2026 | 5.712 |
| September 29, 2026 | 5.754 |
| September 28, 2026 | 5.847 |
| September 25, 2026 | 5.754 |
| September 24, 2026 | 5.630 |
| September 23, 2026 | 5.597 |
| September 22, 2026 | 5.698 |
| September 21, 2026 | 5.732 |
| September 18, 2026 | 5.772 |
| September 17, 2026 | 5.752 |
| September 16, 2026 | 5.822 |
| September 15, 2026 | 5.834 |
| September 14, 2026 | 5.868 |
| September 11, 2026 | 5.825 |
| September 10, 2026 | 5.835 |
| September 09, 2026 | 5.896 |
| September 08, 2026 | 5.922 |
| September 04, 2026 | 6.116 |
| September 03, 2026 | 6.233 |
| September 02, 2026 | 6.193 |
| September 01, 2026 | 6.126 |
| August 31, 2026 | 6.116 |
| August 28, 2026 | 6.094 |
| Date | Value |
|---|---|
| August 27, 2026 | 6.128 |
| August 26, 2026 | 6.185 |
| August 25, 2026 | 6.217 |
| August 24, 2026 | 6.159 |
| August 21, 2026 | 6.134 |
| August 20, 2026 | 5.993 |
| August 19, 2026 | 6.189 |
| August 18, 2026 | 6.046 |
| August 17, 2026 | 5.916 |
| August 14, 2026 | 5.843 |
| August 13, 2026 | 5.918 |
| August 12, 2026 | 5.831 |
| August 11, 2026 | 5.823 |
| August 10, 2026 | 5.935 |
| August 07, 2026 | 5.924 |
| August 06, 2026 | 5.872 |
| August 05, 2026 | 5.824 |
| August 04, 2026 | 6.031 |
| August 03, 2026 | 5.993 |
| July 31, 2026 | 5.978 |
| July 30, 2026 | 5.937 |
| July 29, 2026 | 5.776 |
| July 28, 2026 | 5.822 |
| July 27, 2026 | 5.726 |
| July 24, 2026 | 5.684 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.256 |
| Eli Lilly & Co. | 31.76 |
| Merck & Co., Inc. | 8.495 |
| Pfizer Inc. | 1.860 |
| AstraZeneca PLC | 10.28 |
Price to Book Value Related Metrics
| PE Ratio | 13.47 |
| PS Ratio | 2.540 |
| PEG Ratio | 0.162 |
| Price to Free Cash Flow | 10.92 |
| Price | 61.15 |
| Earnings Yield | 7.42% |
| Market Cap | 124.93B |
| PEGY Ratio | 0.1543 |
| Operating PE Ratio | 7.852 |
| Normalized PE Ratio | 9.956 |